Arlington Trust Co LLC XLV SPDR Health Care Select Sector

Ownership history in Arlington Trust Co LLC  ·  10 quarters on record

AI Ownership Summary

Arlington Trust Co LLC reported SPDR Health Care Select Sector (XLV) in 10 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.18% in 2023 Q4. The latest visible filing shows XLV at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this XLV ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Arlington Trust Co LLC's position in SPDR Health Care Select Sector, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

XLV was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.18% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Arlington Trust Co LLC held XLV — position size vs. price
% of Fund (quarterly)    XLV price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 98.7% -4.9% 75 -5,539 -98.7% 0.00% $12K 2026-01-30 $154.11
2025 Q3 UNCHANGED 5,614 0% 0.14% $781K 2025-10-28 $144.24
2025 Q2 UNCHANGED 5,614 0% 0.15% $757K 2025-07-08 $133.24
2025 Q1 ADDED 5,614 +500 +9.8% 0.17% $820K 2025-04-28 $136.17
2024 Q4 ADDED 5,114 +375 +7.9% 0.15% $704K 2025-01-29 $142.56
2024 Q3 UNCHANGED 4,739 0% 0.16% $730K 2024-10-29 $144.58
2024 Q2 ADDED 4,739 +239 +5.3% 0.16% $691K 2024-08-06 $143.18
2024 Q1 REDUCED 4,500 -193 -4.1% 0.17% $665K 2024-04-16 $134.09
2023 Q4 UNCHANGED 4,693 0% 0.18% $640K 2024-01-24 $133.61
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Arlington Trust Co LLC and XLV

These are the practical questions this page is built to answer before you even open the full history table.

How long has Arlington Trust Co LLC reported owning XLV?

Arlington Trust Co LLC reported XLV across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported XLV position in Arlington Trust Co LLC's portfolio?

The largest reported portfolio weight for XLV was 0.18% in 2023 Q4.

What is the latest reported XLV position on this page?

The most recent filing on this page is 2025 Q4, when Arlington Trust Co LLC reported 75 shares, equal to 0.00% of portfolio, with an estimated market value of $12K.

What does the chart on this XLV ownership page compare?

The chart compares Arlington Trust Co LLC's quarterly XLV portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Arlington Trust Co LLC time their XLV position?

Based on 13F filing dates vs. subsequent XLV price moves, Arlington Trust Co LLC correctly timed 2 out of 5 reported position changes (40%). The annualised alpha on XLV relative to SPY over the holding period was -12.0%.

← Back to Arlington Trust Co LLC Holdings